The sense of smell is interrelated with psychosocial functioning. Olfactory disorders often
decrease quality of life but treatment options for people with olfactory loss are limited …

Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …

This study prospectively assessed the 6-month prevalence of self-reported and
psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID …

Background Respiratory tract viruses are the second most common cause of olfactory
dysfunction. As we learn more about the effects of severe acute respiratory syndrome …

Background Disorders of the sense of smell have received greater attention because of the
frequency with which they occur as a symptom of SARS-CoV-2 infection. Olfactory …

The year 2020 became the year of the outbreak of coronavirus, SARS-CoV-2, which
escalated into a worldwide pandemic and continued into 2021. One of the unique symptoms …

Objective To characterize the clinical features, risk factors, symptom time‐course, and quality
of life implications for parosmia among coronavirus disease (COVID)‐related olfactory …

Background Nearly 40% of patients who experience smell loss during SARS-CoV-2
infection may develop qualitative olfactory dysfunction, most commonly parosmia. Our …